Dexcom Announces Upcoming Virtual Conference Presentations
DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on Dexcom at the following upcoming virtual investor conferences:
- Steve Pacelli, Executive Vice President Strategy and Corporate Development, and Jereme Sylvain, Senior Vice President, Finance and Chief Accounting Officer, will present on behalf of the company at the Baird 2020 Global Healthcare Conference on Wednesday, September 9, 2020 at 4:20pm (EST).
- Steve Pacelli, Executive Vice President Strategy and Corporate Development, and Jereme Sylvain, Senior Vice President, Finance and Chief Accounting Officer, will present on behalf of the company at the Wells Fargo 2020 Virtual Healthcare Conference on Thursday, September 10, 2020 at 11:20am (EST).
- Quentin Blackford, Chief Operating Officer and Chief Financial Officer, will present on behalf of the company at the Morgan Stanley 18th Annual Healthcare Conference on Tuesday, September 15, 2020 at 11:00am (EST).
Links to the webcasts will be available on the Dexcom Investor Relations website at investors.dexcom.com/ and will be archived there for future reference.
About DexCom, Inc.
DexCom, Inc. empowers people to take control of diabetes through innovative continuous glucose monitoring (CGM) products. Headquartered in San Diego, California, Dexcom has emerged as a leader of diabetes care technology. By listening to the needs of patients, caregivers, and clinicians, Dexcom simplifies and improves diabetes management around the world.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200904005138/en/
Dexcom Inc. Stock
With 25 Buy predictions and not a single Sell prediction Dexcom Inc. is an absolute favorite of our community.
As a result the target price of 121 € shows a very positive potential of 86.15% compared to the current price of 65.0 € for Dexcom Inc..
